Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic stem cell transplant in metastatic breast cancer
NCT00020176Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2000
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic allogeneic lymphocytes in breast cancer, sponsored by National Cancer Institute. Started Jun 2000; status: completed.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00020176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020176.